DrugPatentWatch Database Preview
Usl Pharma Company Profile
» See Plans and Pricing
What is the competitive landscape for USL PHARMA, and what generic and branded alternatives to USL PHARMA drugs are available?
USL PHARMA has one hundred and three approved drugs.
Summary for Usl Pharma
| US Patents: | 0 |
| Tradenames: | 56 |
| Ingredients: | 54 |
| NDAs: | 103 |
Drugs and US Patents for Usl Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Usl Pharma | PHENDIMETRAZINE TARTRATE | phendimetrazine tartrate | TABLET;ORAL | 084398-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| Usl Pharma | METHYCLOTHIAZIDE | methyclothiazide | TABLET;ORAL | 088745-001 | Mar 21, 1985 | DISCN | No | No | Start Trial | Start Trial | |||||
| Usl Pharma | TOLAZAMIDE | tolazamide | TABLET;ORAL | 070169-001 | Apr 2, 1986 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
